ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,257Medicare Part D Prescriptions Filled, Including Refills

Rank: 40 out of 1019

$547K Total Retail Price of All Prescriptions

Rank: 75 out of 1019

1,097 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 1,097 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

0% of this provider’s 8,697 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

9 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
METOPROLOL SUCCINATE 1,227 1,024 1 1
AMLODIPINE BESYLATE 715 645 2 4
ISOSORBIDE MONONITRATE ER 680 562 3 12
CLOPIDOGREL 620 535 4 7
PLAVIX 510 420 5 11
CRESTOR 437 346 6 13
ENALAPRIL MALEATE 387 311 7 38
WARFARIN SODIUM 354 300 8 9
DIGOXIN 350 298 9 14
METOPROLOL TARTRATE 268 222 10 8
FUROSEMIDE 253 211 11 6
PRAVASTATIN SODIUM 253 235 11 16
ATORVASTATIN CALCIUM 239 224 13 10
CARVEDILOL 208 162 14 3
DIOVAN 203 169 15 20
LISINOPRIL 190 169 16 2
HYDRALAZINE HCL 175 147 17 34
PRADAXA 144 129 18 24
HYDROCHLOROTHIAZIDE 123 97 19 18
NITROSTAT 116 84 20 27
BISOPROLOL FUMARATE 115 96 21 43
PANTOPRAZOLE SODIUM 113 112 22 46
POTASSIUM CHLORIDE 112 104 23 15
RANEXA 108 89 24 32
JANTOVEN 96 90 25 73
TRILIPIX 92 84 26 70
LOSARTAN POTASSIUM 83 69 27 17
SPIRONOLACTONE 82 67 28 23
LIPITOR 81 66 29 37
AMLODIPINE BESYLATE-BENAZEPRIL 74 52 30 47
NIASPAN 71 64 31 33
DIOVAN HCT 71 63 31 39
LOVAZA 63 53 33 60
BENAZEPRIL HCL 62 43 34 69
RAMIPRIL 54 30 35 21
LABETALOL HCL 54 45 35 63
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 1, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.